UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 5, 2014
CANNAPHARMARX, INC.
---------------------
(Exact name of Registrant as specified in its charter)
Delaware 000-27055 24-4635140
---------------------------- -------------------------- ---------------------
(State or other jurisdiction (Commission File Number) (IRS Employer Identi-
of incorporation) fication No.)
One Collins Drive, Salem Business Center, Carneys Point, NJ 08069-3640
--------------------------------------------------
(Address of principal executive offices)
720-939-1133
-----------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
-----------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Officers; Compensatory Arrangements of Certain Officers
See Item 5.07 below.
Item 5.07 Submission of Mattes to a Vote of Security Holders
Appointment of Directors
------------------------
On December 5, 2014, the Company held its Annual Meeting of Shareholders. At the
meeting, the following directors were elected to hold office until the next
Annual Meeting of Shareholders:
Gerry Crocker
Gary Herick
James Smeeding
Robert Liess
Mathew Sherwood
A total of 9,000,000 shares voted in favor of the appointment of the
above-mentioned director. No votes abstained, and no votes voted against the
above-mentioned directors.
Ratification of Appointment of Auditor
--------------------------------------
At the Annual Meeting of Shareholders, the shareholders voted in favor of
ratifying the appointment of the Company's auditors, KLJ & Associates, LLP for
the fiscal year ended 2014. A total of 9,000,000 shares voted in favor of the
appointment. No votes abstained, and no votes voted against the proposal.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CANNAPHARMRARX, INC.
By: /s/ Gerry Crocker
-----------------------------------------
Gerry Crocker
Chief Executive Officer
Date: December 8, 201
